✦ LIBER ✦

Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052

✍ Scribed by Fridell, R. A.; Qiu, D.; Valera, L.; Wang, C.; Rose, R. E.; Gao, M.

Book ID: 126286457
Publisher: American Society for Microbiology
Year: 2011
Tongue: English
Weight: 691 KB
Volume: 85
Category: Article
ISSN: 0022-538X
DOI: 10.1128/JVI.00253-11

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of hepatitis C virus variants

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

✍ Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Yuya Seko; Yusuke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Multiple ascending dose study of BMS-790

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1

✍ Richard E. Nettles; Min Gao; Marc Bifano; Ellen Chung; Anna Persson; Thomas C. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Abbreviations: AE, adverse event; AUC, area under the plasma concentration time curve; AUC (TAU) , AUC over 12-hour dosing interval for 30 mg twice daily; C min , minimum observed plasma concentration; C max , maximum observed plasma concentration; C trough , trough concentrations; CLT/F, apparent t

A hepatitis C virus NS4B inhibitor suppr

A hepatitis C virus NS4B inhibitor suppresses viral genome replication by disrupting NS4B’s dimerization/multimerization as well as its interaction with NS5A

✍ Moonju Choi, Sungjin Lee, Taekyu Choi, Choongho Lee 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 893 KB

Discovery of Daclatasvir, a Pan-Genotypi

Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect

✍ Belema, Makonen; Meanwell, Nicholas A. 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 800 KB

In Vitro Activity and Resistance Profile

In Vitro Activity and Resistance Profile of Samatasvir, a Novel NS5A Replication Inhibitor of Hepatitis C Virus

✍ Bilello, J. P.; Lallos, L. B.; McCarville, J. F.; La Colla, M.; Serra, I.; Chapr 📂 Article 📅 2014 🏛 American Society for Microbiology 🌐 English ⚖ 569 KB

Impact of a baseline polymorphism on the

Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052

✍ Jin-Hua Sun; Donald R. O'Boyle II; Yan Zhang; Chunfu Wang; Peter Nower; Lourdes 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB